Publications 2003

Centre for Genetic Epidemiology
Epidemiology and Biostatistics Unit

Publications from the Centre for Genetic Epidemiology:

• Cui J, Spurdle B, Southey M, Dite G, Venter D, McCredie M, Giles G, Chenevix-Trench G, Hopper J. 2003. Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Genetic Epidemiology. 24:161-172.

• Staples P, Giles G, English R, McCredie M, Severi G, Cui J, Hopper JL. 2003. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes & Control. 14:161-166.

• Cui J, Hopper JL, Harrap, SB. 2003. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 41: 207-210

• Osborne R, Elsworth G, Hopper JL 2003. Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. European Journal of Cancer. 39:755-762.

• Fisher T, Kirk J, Hopper JL, Godding R, Burgemeister FC. 2003. A simple tool for identifying unaffected women at a moderately increased or potentially high risk of breast cancer based on their family history. The Breast. 12:120-127.

• Dite GS, Jenkins MA, Southey MC, Hocking S, Giles G, McCredie M, Venter DJ, Hopper JL. 2003. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. Journal of the National Cancer Institute. 95(6):448-457.

• Scott C, Jenkins MA, Southey MC, Davis A, Leary J, Easton F, Phillips KA, Hopper JL. 2003. Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics. Human Genetics. 112:542-551.

• Provenzano E, Hopper JL, Giles G, Marr G, Venter DJ, Armes JE. 2003. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. European Journal of Cancer. 39:622-630.

• Antoniou A, Pharoah PD, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo L, Evans DG, Easton. 2003. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics. 72:1117-1130.

• White VM, Hopper JL, Wearing AJ, Hill DJ. 2003. The role of genes in tobacco smoking during adolescence and young adulthood: a multivariate behaviour genetic investigation. Addiction. 98:1087-1100.

• Giles G, Severi G, English R, McCredie M, Borland R, Boyle P, Hopper JL. 2003. Sexual factors and prostate cancer. BJU International. 92(3):211-216.

• Flicker L, Mead KE, MacInnis R, Nowson CA, Scherer C, Stein MS, ThomaS J, Hopper JL, Wark JD. 2003. Serum vitamin D and falls in older women in residential care in Australia. Journal of the American Geriatrics Society. 51:1533-1538.

• Visscher P, Henriksen JE, Hopper JL, Sorensen T, Kyvik KO. 2003. Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia. 46:1276-1283.

• Chau P, Yip SF, Cui J. 2003. Reconstructing the incidence of human immunodeficiency virus (HIV) in Hong Kong by using data from HIV positive tests and diagnoses of acquired immune deficiency syndrome. Royal Statistical Society - Series C: Applied Statistics. 52(2):237-248.

• Southey MC, Tesoriero A, Young M-A, Holloway AJ, Jenkins MA, Whitty J, Misfud S, KCONFAB, McLachlan S, Venter DJ, Armes, JE. 2003. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Human Mutation. 22:86-91.

• Severi G, Giles G, Southey MC, Tesoriero AA, Tilley W, Neufing P, Morris H, English R, McCredoe M, Boyle P, Hopper JL. 2003. ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. Journal of the National Cancer Institute. 95(11): 818-824.

• Apicella C, Andrews L, Hodgson SV, Fisher SA, Lewis CM, Solomon E, Tucker K, Friedlander M, Bankier A, Southey MC, Venter DJ, Hopper JL. 2003. Log odds of carrying an ancestral mutation in BRCA1 or BRCA2 for a defined personal and family history in an Ashkenazi Jewish woman (LAMBDA). Breast Cancer Research. 5(6): R206-R216.

• McCredie M, Dite GS, Southey MC, Venter DJ, Giles G, Hopper JL. 2003. Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. British Journal of Cancer. 89:1661-1663.

• Gertig DM, Erbas B, Fletcher ASR, Amos A, Kavanagh AM. 2003. Duration of hormone replacement therapy, breast tumour size and grade in a screening programme. Breast Cancer Research and Treatment. 80:267-273.

• Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie M, Giles G, Southey MC, Hopper JL, Campbell IG. 2003. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiology, Biomarkers & Prevention. 12:1109-1111.

• Auranen A, Spurdle A, Chen X, Lipscombe J, Purdie M, Hopper JL, Green A, Healey CS, Redman K, Dunning AM, Pharoah PD, Easton F, Ponder BAJ, Chenevix-Trench G, Novik KL. 2003. BRCA2 Arg372His polymorphism and epithelial ovarian cancer risk. International Journal of Cancer. 103:427-430.

• Severi G, Sinclair RD, Hopper JL, English D, McCredie M, Boyle P, Giles G. 2003. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. British Journal of Dermatology. 149:1207-1213.

• MacInnis R, English R, Gertig DM, Hopper JL, Giles G. 2003. Body size and composition and prostate cancer risk. Cancer Epidemiology Biomarkers and Prevention. 12(Dec):1417-1421.

• MacInnis R, Cassar CL, Nowson CA, Paton LM, Flicker L, Hopper JL, Larkins RG, Wark JD. 2003. Determinants of bone density in 30- to 65-year-old women: A co-twin study. Journal of Bone and Mineral Research. 18(9):1650-1656.

• Thorstenson R, Roxas A, Kroiss R, Jenkins MA, Yu K, Bachrich T, Muhr D, Wayne TL,
  Chu G, Davis RW, Wagner T, Oefner PJ. 2003. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Research. 63:3325-3333

• Johnson MR, Milne RL, Torn-Broers Y, Hopper JL, Scheffer IE, Berkovic SF. 2003. A twin study of genetic influences on Epilepsy outcome. Twin Research. 6(2):140-146.

• Njajou T, Houwing-Duistermaat J, Osborne R, Vaessen N, Vergeer J, Heeringa J, Pols H, Hofman A, Van Duijn CM. 2003. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. European Journal of Human Genetics. 11:225-231.

• Edwards S, Meitz J, Hope Q, Bullock S, Hamoudi R, Adern-Jones A, Southgate C,
  Dowe A, Coleman K, Dearnaley D, Eeles Ra, Evans C, Teare D, Easton F, Hopper Jl, Giles G, English R, Southey Mc, Foulkes Wd, Hamel N, Narod Sa, Simard J, Badzioch M, Amos C, Heimdal K, Mahle L, Moller P, Wessel N, Andersen T, Bishop DT. 2003. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE Consortium. Prostate. 57:270-279.

• Moller P, Wessel N, Andersen T, Bishop DT. 2003. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE Consortium. Prostate. 57:270-279.

• Hopper JL. 2003. Commentary: Case-control-family designs: a paradigm for future epidemiology research? International Journal of Epidemiology. 32:48-50.

• Hopper JL, Baron JA. 2003. Re: oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 95(13):1010-1011.

• Hopper JL, Boyd NF. 2003. Mammographic density of the breast. New England Journal of Medicine. 348(2):174-175.

• Pharoah PD, Antoniou A, Hopper JL, Easton F. 2003. Re: On the use of familial aggregation in population-based case probands for calculating penetrance. Journal of the National Cancer Institute. 95(1):75-76.

• Gertig DM, Hopper JL, Allen KJ. 2003. Population genetic screening for hereditary haemochromatosis. Medical Journal of Australia. 179(10):517-518.

Publications from the Epidemiology and Biostatistics Unit:

• Leslie K, Troedel S, Irwin K, Pearce F, Ugoni AM, Gillies R, Pemberton E, Dharmage SC. 2003. Quality of recovery from anesthesia in neurosurgical patients. Anesthesiology. 99:1158-1165.

• Lowe AJ, Campbell DA, Walker P, Farish SJ, Jackson B, Dharmage SC. 2003. Clustering effects of chronic obstructive pulmonary disease specific quality of life in hospitalized patients. Respirology. 8:339-343.

• Cooper EE, O'Reilly MA, Guest DI, Dharmage SC. 2003. Influence of building construction work on Aspergillus infection in a hospital setting. Infection Control and Hospital Epidemiology. 24(7): 472-475.

• Matheson M, Dharmage SC, Forbes AB, Raven J, Woods RK, Thien F, Guest DI, Rolland J, Walters EH, Abramson M. 2003. Residential characteristics predict changes in Der p 1, Fel d 1 and ergosterol but not fungi over time. Clinical and Experimental Allergy. 33:1281-1288.

• Bennett CM, Dalton C, Beers-Deeble M, Milazzo A, Kraa E, Davos D, Puech M, Tan Agc, Heuzenroeder Mw. 2003. Fresh garlic: a possible vehicle for Salmonella Virchow. Epidemiology and Infection. 131:1041-1048.

• Staff M, Bennett CM, Angel P. 2003. Is restricting tobacco sales the answer to adolescent smoking? Preventive Medicine. 37:529-533.

Date created:

11 Aug 2006 3:26pm

Last modified:

25 May 2007 12:22pm

Authoriser:

Director, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health

Maintainer:

EPI webmaster

Email:

epi-info@unimelb.edu.au

• The University of Melbourne ABN: 84 002 705 224
• CRICOS Provider Number: 00116K : More information
• Disclaimer & copyright
• Accessibility
• Privacy